{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:49:31Z","timestamp":1790675371828,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":2877,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s13311-015-0373-7","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T09:50:44Z","timestamp":1439373044000},"page":"807-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage"],"prefix":"10.1016","volume":"12","author":[{"given":"Yasmin L.","family":"Hurd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex F.","family":"Manini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Olmedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ostman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-015-0373-7_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"Elsohly","year":"2005","journal-title":"Life Sci"},{"key":"10.1007\/s13311-015-0373-7_bib2","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol\u2014recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1007\/s13311-015-0373-7_bib3","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1556-4029.2010.01441.x","article-title":"Potency trends of \u03949-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008","volume":"55","author":"Mehmedic","year":"2010","journal-title":"J Forensic Sci"},{"key":"10.1007\/s13311-015-0373-7_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/epi.12635","article-title":"The case for assessing cannabidiol in epilepsy","volume":"55","author":"Cilio","year":"2014","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-015-0373-7_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-015-0373-7_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1151\/spp05314","article-title":"The neurobiology of cocaine addiction","volume":"3","author":"Nestler","year":"2005","journal-title":"Sci Pract Perspect"},{"key":"10.1007\/s13311-015-0373-7_bib7","doi-asserted-by":"crossref","unstructured":"Galanter M, Kleber HD. The American Psychiatric Publishing textbook of substance abuse treatment. 4th ed. American Psychiatric Publishing, Washington, DC, 2008.","DOI":"10.1176\/appi.books.9781585623440"},{"key":"10.1007\/s13311-015-0373-7_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","article-title":"The National Treatment Outcome Research Study (NTORS): 4\u20135 year follow-up results","volume":"98","author":"Gossop","year":"2003","journal-title":"Addiction"},{"key":"10.1007\/s13311-015-0373-7_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.15288\/jsad.2007.68.641","article-title":"Cocaine craving as a predictor of treatment attrition and outcomes after residential treatment for cocaine dependence","volume":"68","author":"Rohsenow","year":"2007","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1007\/s13311-015-0373-7_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-010-1884-x","article-title":"Daily life hour by hour, with and without cocaine: an ecological momentary assessment study","volume":"211","author":"Epstein","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.npp.1301470","article-title":"Enhanced sensitivity to stress and drug\/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers","volume":"33","author":"Fox","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.drugalcdep.2007.10.002","article-title":"Craving predicts time to cocaine relapse: further validation of the Now and Brief versions of the cocaine craving questionnaire","volume":"93","author":"Paliwal","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1007\/s13311-015-0373-7_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/archgenpsychiatry.2008.509","article-title":"Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use","volume":"66","author":"Epstein","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1007\/s13311-015-0373-7_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-009-1655-8","article-title":"Cocaine craving and use during daily life","volume":"207","author":"Preston","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0373-7_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.63.3.324","article-title":"Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes","volume":"63","author":"Sinha","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1007\/s13311-015-0373-7_bib16","doi-asserted-by":"crossref","unstructured":"Knapp WP, Soares BG, Farrel M, Lima MS. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev 2007:CD003023.","DOI":"10.1002\/14651858.CD003023.pub2"},{"key":"10.1007\/s13311-015-0373-7_bib17","doi-asserted-by":"crossref","unstructured":"Amato L, Minozzi S, Pani PP, Davoli M. Antipsychotic medications for cocaine dependence. Cochrane Database Syst Rev 2007:CD006306.","DOI":"10.1002\/14651858.CD006306"},{"key":"10.1007\/s13311-015-0373-7_bib18","doi-asserted-by":"crossref","unstructured":"Lima MS, Reisser AA, Soares BG, Farrell M. Antidepressants for cocaine dependence. Cochrane Database Syst Rev 2003:CD002950.","DOI":"10.1002\/14651858.CD002023"},{"key":"10.1007\/s13311-015-0373-7_bib19","doi-asserted-by":"crossref","unstructured":"Minozzi S, Amato L, Davoli M, et al. Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev 2008:CD006754.","DOI":"10.1002\/14651858.CD006754.pub2"},{"key":"10.1007\/s13311-015-0373-7_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1007\/s13311-015-0373-7_bib21","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.vaccine.2014.07.085","article-title":"Adjuvants for vaccines to drugs of abuse and addiction","volume":"32","author":"Alving","year":"2014","journal-title":"Vaccine"},{"key":"10.1007\/s13311-015-0373-7_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","article-title":"Ultrastructural localization of the CB1 cannabinoid receptor in mu- opioid receptor patches of the rat Caudate putamen nucleus","volume":"21","author":"Rodriguez","year":"2001","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0373-7_bib23","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0373-7_bib24","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-015-0373-7_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib27","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons","volume":"28","author":"Qin","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0373-7_bib28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib30","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","article-title":"Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation","volume":"159","author":"Magen","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1007\/s13311-015-0373-7_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.phrs.2010.05.003","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors","volume":"62","author":"Alves","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1007\/s13311-015-0373-7_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0269881110389095","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors","volume":"26","author":"Gomes","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","article-title":"Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors","volume":"213","author":"Soares Vde","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-015-0373-7_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2011.01.013","article-title":"Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum","volume":"655","author":"Pandolfo","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib38","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0373-7_bib39","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212)Delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0373-7_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pnpbp.2010.11.002","article-title":"The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects","volume":"35","author":"Hallak","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0373-7_bib41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimaraes","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-3623(94)90027-2","article-title":"Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze","volume":"25","author":"Guimaraes","year":"1994","journal-title":"Gen Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib43","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0373-7_bib44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.pbb.2011.06.027","article-title":"Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress","volume":"99","author":"Granjeiro","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1007\/s13311-015-0373-7_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/npp.2011.188","article-title":"Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm","volume":"37","author":"Uribe-Marino","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib46","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00213-011-2449-3","article-title":"Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders","volume":"219","author":"Fagherazzi","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0373-7_bib47","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1476-5381.2010.01179.x","article-title":"Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice","volume":"162","author":"Avraham","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2010.06.023","article-title":"Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture","volume":"1348","author":"Cassol-Jr","year":"2010","journal-title":"Brain Res"},{"key":"10.1007\/s13311-015-0373-7_bib49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1007\/s13311-015-0373-7_bib50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0373-7_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib52","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/taap.1998.8403","article-title":"Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity","volume":"150","author":"Bornheim","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib53","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/jpet.105.085779","article-title":"Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity","volume":"314","author":"Hamelink","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0373-7_bib54","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3181\/00379727-180-42181","article-title":"Effects and interactions of natural cannabinoids on the isolated heart","volume":"180","author":"Nahas","year":"1985","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1007\/s13311-015-0373-7_bib55","first-page":"191","article-title":"Antagonistic effects of two natural cannabinoids on the isolated heart","volume":"297","author":"Trouve","year":"1983","journal-title":"C R Seances Acad Sci III"},{"key":"10.1007\/s13311-015-0373-7_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S1461145709990605","article-title":"A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice","volume":"13","author":"Long","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib58","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0269881106060967","article-title":"Cannabidiol monotherapy for treatment-resistant schizophrenia","volume":"20","author":"Zuardi","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0269881108096521","article-title":"Cannabidiol was ineffective for manic episode of bipolar affective disorder","volume":"24","author":"Zuardi","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib60","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"Zuardi","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-015-0373-7_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1007\/s13311-015-0373-7_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib64","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl. 1","key":"10.1007\/s13311-015-0373-7_bib66","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S1516-4446(12)70057-0","article-title":"Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug","volume":"34","author":"Schier","year":"2012","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1007\/s13311-015-0373-7_bib67","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1523\/JNEUROSCI.5129-07.2008","article-title":"Glutamate release in the nucleus accumbens core is necessary for heroin seeking","volume":"28","author":"LaLumiere","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0373-7_bib68","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat Med"},{"key":"10.1007\/s13311-015-0373-7_bib69","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0373-7_bib70","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2007.11.017","article-title":"Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol","volume":"94","author":"Vann","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1007\/s13311-015-0373-7_bib71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addict Biol"},{"key":"10.1007\/s13311-015-0373-7_bib72","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0373-7_bib73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2008.12.003","article-title":"Glutamate and reinstatement","volume":"9","author":"Knackstedt","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib74","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0024-3205(75)90435-X","article-title":"Interactions between cannabidiol and delta9-THC during abstinence in morphine-dependent rats","volume":"17","author":"Hine","year":"1975","journal-title":"Life Sci"},{"key":"10.1007\/s13311-015-0373-7_bib75","first-page":"185","article-title":"Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats","volume":"12","author":"Hine","year":"1975","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1007\/s13311-015-0373-7_bib76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0091-3057(85)90122-4","article-title":"The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol","volume":"23","author":"Chesher","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1007\/s13311-015-0373-7_bib77","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00426828","article-title":"Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice","volume":"49","author":"Bhargava","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib78","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-011-2342-0","article-title":"Cannabidiol potentiates Delta(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats","volume":"218","author":"Klein","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0373-7_bib79","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addict Behav"},{"key":"10.1007\/s13311-015-0373-7_bib80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]","volume":"197","author":"Morgan","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1007\/s13311-015-0373-7_bib81","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/npp.2010.58","article-title":"Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis","volume":"35","author":"Morgan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0373-7_bib82","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/ADM.0000000000000118","article-title":"Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans","volume":"9","author":"Manini","year":"2015","journal-title":"J Addict Med"},{"key":"10.1007\/s13311-015-0373-7_bib83","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-015-0373-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0373-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:45:50Z","timestamp":1761806750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923008127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1878747923008127"],"URL":"https:\/\/doi.org\/10.1007\/s13311-015-0373-7","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-015-0373-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}